Given that carotid atherosclerosis is associated with an increased risk of cardiovascular disease and low serum adropin level may be involved in promotion of carotid atherosclerosis, adropin may thus be a useful agent in preventing atherosclerosis and its progression. This evidence concerns the gene ENHO and cardiovascular disorder.